Prevention of Anhedonia in Children (NCT05988138) | Clinical Trial Compass
CompletedNot Applicable
Prevention of Anhedonia in Children
United States73 participantsStarted 2023-11-10
Plain-language summary
This trial will test the effects of a positive emotion-focused preventive intervention on reward responsiveness in children of mothers with histories of depression and anhedonia.
Who can participate
Age range8 Years – 12 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Biological mothers with past or current MDD with anhedonia and their 8- to 12-year-old children
* Child and biological mother can read and speak fluently in English
* Child and mother have access to a computer or tablet and internet for videoconferencing
* For compensation purposes, child and biological mothers must be U.S. citizens
Exclusion Criteria:
* Children with past or current major depressive disorder (MDD) and/or anhedonia lasting most of the day, nearly every day for at least 2 weeks based on semi-structured interviews will be excluded
* Mothers or children with intellectual or developmental disabilities
* Mothers with past 6 months substance use disorder with moderate or greater severity
* Children or mothers with a lifetime history of a manic or hypomanic episode/bipolar disorder
* Children or mothers with a psychotic disorder (e.g., schizophrenia)
* Children or mothers with visual or hearing impairments that interfere with completing study measures and sessions
* Child offspring of a mother who has previously participated in the study with another biological child
* Children taking medications for emotional or behavioral problems other than SSRIs (stable dose for 6 weeks before time of enrollment) or psychostimulants
What they're measuring
1
Neural responses to rewards measured by electroencephalogram (EEG) in a computerized guessing reward task (physiological measure)